RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Obstetrics Channel

subscribe to Obstetrics newsletter
Latest Research : Obstetrics

   EMAIL   |   PRINT
Diagnosing preeclampsia with proteomic analysis

Feb 4, 2006 - 9:29:00 PM , Reviewed by: Priya Saxena
"The presence of a combination of specific fragments of albumin and serpina-1 are highly characteristic for preeclampsia superimposed on chronic hypertension or not," said Buhimschi. "By identifying these protein biomarkers we gained further insight into the mechanisms related to the development of PE."

 
[RxPG] Researchers at Yale School of Medicine have found that analyzing proteins in urine is a simple and objective method to diagnose and classify preeclampsia (PE), a complication of pregnancy causing high blood pressure after 20 weeks of gestation.

Delivery of the baby is the only treatment for PE, which is more prevalent in obese, older, diabetic and black women. Buhimschi and her team had the goal of discovering a biomarker for predicting, diagnosing and monitoring severity and treatment effectiveness of PE.

The team analyzed 122 urine samples collected prospectively from different patients. The team applied proteomics to define the best combination of urinary biomarkers that set PE apart from other proteinuric hypertensive conditions during pregnancy.

"The presence of a combination of specific fragments of albumin and serpina-1 are highly characteristic for preeclampsia superimposed on chronic hypertension or not," said Buhimschi. "By identifying these protein biomarkers we gained further insight into the mechanisms related to the development of PE."

"This can lead to earlier diagnosis and treatment of PE and can help prevent unnecessary pre-term deliveries," Buhimschi added.



Publication: The work will be presented at the 26th Annual Society for Maternal-Fetal Medicine (SMFM) meeting on February 3 by Irina A. Buhimschi, M.D., assistant professor in the Department of Obstetrics, Gynecology & Reproductive Sciences.
On the web: www.yale.edu 

Advertise in this space for $10 per month. Contact us today.


Related Obstetrics News
progesterone can prevent apoptosis in fetal membranes and therefore prevent pre-term birth
Anxious women more likely to have smaller babies
Preeclampsia -a disorder of protein misfolding
Depression during pregnancy doubles risk of premature delivery
Computer programme to predict premature births under development
Predictor of miscarriages
Elevated autoantibodies linked to preeclampsia
Vitamin D intake inadequate during pregnancy
Non-invasive alternative to amniocentesis ?
Advanced Maternal Age is an Independent Predictor of Intrauterine Fetal Death at Term

Subscribe to Obstetrics Newsletter

Enter your email address:


 Additional information about the news article
In addition to this abstract, Yale University has the most presentations at SMFM obtained competitively via extramural funding.

Other authors on this research included Guomao Zhao, M.D., Edmund Funai, M.D., George R. Saade, M.D., and Catalin Buhimschi, M.D.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)